Amgen Stock Falls on Weight Loss Drug's Bone Density Loss Data
Omar Marqués | Light rocket | fake images Actions of amgen fell more than 7% on Tuesday as analysts analyzed…
LILLY DRN
Race for weight-loss drugs intensifies with data on obesity pills
Aykut Karahan | Stock | fake images A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing…
Why sales of Eli Lilly's Zepbound and Mounjaro fell short
Eli LillyBlockbuster weight-loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as supplies of…
Eli Lilly (LLY) earnings in the third quarter of 2024
The Lilly Biotechnology Center is shown in San Diego, California, USA, on March 1, 2023. Mike Blake | Reuters Eli…
Novo Nordisk's Ozempic and Wegovy are now available after shortages
Packages containing syringes of the drugs Wegovy, Ozempic and Mounjaro in a store in Mitte, Germany, on July 11, 2024.…
Novo Nordisk asks FDA to ban compound copies of Ozempic and Wegovy
Nordisk On Tuesday it asked the Food and Drug Administration to stop compounding pharmacies from making unapproved and often cheaper…
Novo Nordisk's Ozempic May Reduce Alzheimer's Disease Risk: Study
Steve Christo – Corbis | Corbis News | fake images NordiskThe blockbuster diabetes drug Ozempic may reduce the risk of…
UK, Eli Lilly to trial use of weight loss drugs to combat unemployment
LONDON – American pharmaceutical giant Eli Lilly is exploring whether anti-obesity drugs could be used to curb unemployment after signing…
Medicare weight-loss drug coverage could cost $34 billion
A merged image shows an injectable pen of Zepbound, Eli Lilly's weight-loss drug, and boxes of Wegovy, made by Novo…
Eli Lilly to build $4.5 billion research and manufacturing center
Eli Lilly will spend $4.5 billion to build a center to find better ways to make its drugs. The facility,…